Excellthera
ExCellThera is a world leader in enhanced blood stem cell therapies.
7-day free trial · no credit card
Verified contacts
14
available on Kipplo
LinkedIn employees
18
11 to 50 range
Open roles
—
no listings
Distinct roles
14
indexed titles
Tech stack
2
tools in use
Monthly traffic
17
organic / mo
Sign up free to see all 14 verified contacts at Excellthera
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
14 contacts with verified email or phone · masked until revealed.
- GS
Guy Sauvageau
Stem Cell Biologist and Geneticist · Other
EmailPhone - VG
Valérie Gagné
Associée Senior Développement Des Procédés · Other
EmailPhone - DM
David Millette
Chief Executive Officer · General Business & Management
EmailPhone - BL
Bernhard Lehnertz
Director, Stem Cell Engineering · Other
EmailPhone - ET
Elisa Tomellini
Director of Cell Therapy Laboratory · Other
EmailPhone - JD
Josée Demers
Director, Quality Control · Manufacturing & Production
EmailPhone - SR
Shanti Rojas-Sutterlin
Laboratory Director (Cell Therapy Laboratory) · Other
EmailPhone - JP
Jean Proulx
VP, Medical Affairs · Healthcare & Human Services
EmailPhone - SC
Sophie Corneau
Senior Associate - Process Development and Cell Therapy · Research & Development
EmailPhone
Showing 9 of 14 verified contacts
Top roles at Excellthera
14 distinct titles indexed · top 10 shown.
- 1associée senior développement des procédés
- 1cfo
- 1chief executive officer
- 1chief operating officer
- 1director of cell therapy laboratory
- 1director, quality control
- 1director, stem cell engineering
- 1laboratory director (cell therapy laboratory)
- 1quality & data associate
- 1quality assurance associate
- +4more titles
Sign up to unlock all 14 contacts at Excellthera
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 14 verified contacts at Excellthera
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.